A comparison of dynamic characteristics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans using time-kill methodology

被引:31
作者
Burgess, DS [1 ]
Hastings, RW
机构
[1] Univ Texas, Coll Pharm, Austin, TX 78712 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78284 USA
关键词
D O I
10.1016/S0732-8893(00)00173-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
This study evaluated the in vitro pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Cryptococcus neoformans. MICs were determined for three clinical isolates according to NCCLS guidelines (M27). Time-kill studies were performed using antifungal concentrations of 0.25-32xMIC and inocula of 10(3) and 10(5) CFU/ml. At predetermined time points over 72 hours, samples of each inoculum/drug combination were withdrawn and plated using a spiral plater. Colony counts were determined after incubation at 35 degrees C for 48 hours. Area under the kill curves (AUKCs) were plotted versus the AUC/MIC ratios. Inoculum effect was evaluated by calculating an estimated AUKC for the low inoculum then comparing it to the measured low inoculum using the unpaired Student's t-test. The MICs of fluconazole and itraconazole for isolate 97-1199, 97-1061, and 97-585 were 2, 4, 32 mu g/ml and 0.03, 0.06, 0.5 mu g/ml, respectively. For amphotericin B, the MIC was 0.25 mu g/ml for each isolate. The triazoles demonstrated fungistatic activity against each isolate at both inocula with the exception of itraconazole against C. neoformans 97-585. Maximal suppression was noted at concentrations 8-16xMIC correlating with an AUC/MIC of 192 for both inocula. Conversely, amphotericin B was fungicidal and displayed concentration-dependent activity against each isolate at both inocula. Maximal killing was observed at concentrations >4xMIC for the low inoculum and >8xMIC for the high inoculum for each isolate. No statistically significant differences were detected between the measured and estimated AUKCs for each antifungal agent. In conclusion, our results suggest that the triazoles were most effective against C. neoformans when concentrations were maintained at 8-16xMIC. Amphotericin B, on the other hand, was concentration-dependent; thus, greater activity was exerted at higher concentrations. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:87 / 93
页数:7
相关论文
共 24 条
[1]   Pharmacodynamics of fluconazole, itraconazole, and amphotericin B against Candida albicans [J].
Burgess, DS ;
Hastings, RW ;
Summers, KK ;
Hardin, TC ;
Rinaldi, MG .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 36 (01) :13-18
[2]   AMPHOTERICIN-B AS PRIMARY THERAPY FOR CRYPTOCOCCOSIS IN PATIENTS WITH AIDS - RELIABILITY OF RELATIVELY HIGH-DOSES ADMINISTERED OVER A RELATIVELY SHORT-PERIOD [J].
DELALLA, F ;
PELLIZZER, G ;
VAGLIA, A ;
MANFRIN, V ;
FRANZETTI, M ;
FABRIS, P ;
STECCA, C .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (02) :263-266
[3]  
DROMER F, 1996, CLIN INFECT DIS S2, V22, P154
[4]   ROLE OF PHARMACOKINETICS IN THE OUTCOME OF INFECTIONS [J].
DRUSANO, GL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (03) :289-297
[5]   Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: Enzyme activity versus MIC [J].
Firsov, AA ;
Savarino, D ;
Ruble, M ;
Gilbert, D ;
Manzano, B ;
Medeiros, AA ;
Zinner, SH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (03) :734-738
[6]   PHARMACODYNAMICS OF INTRAVENOUS CIPROFLOXACIN IN SERIOUSLY ILL-PATIENTS [J].
FORREST, A ;
NIX, DE ;
BALLOW, CH ;
GOSS, TF ;
BIRMINGHAM, MC ;
SCHENTAG, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) :1073-1081
[7]   Treatment of fungal infection in AIDS [J].
Hood, S ;
Denning, DW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 :71-85
[8]   Antifungal pharmacodynamic characteristics of fluconazole and amphotericin B tested against Candida albicans [J].
Klepser, ME ;
Wolfe, EJ ;
Jones, RN ;
Nightingale, CH ;
Pfaller, MA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1392-1395
[9]   Pharmacodynamics of fluconazole in a murine model of systemic candidiasis [J].
Louie, A ;
Drusano, GL ;
Banerjee, P ;
Liu, QF ;
Liu, WG ;
Kaw, P ;
Shayegani, M ;
Taber, H ;
Miller, MH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (05) :1105-1109
[10]   CLINICAL-RESPONSE TO AMINOGLYCOSIDE THERAPY - IMPORTANCE OF THE RATIO OF PEAK CONCENTRATION TO MINIMAL INHIBITORY CONCENTRATION [J].
MOORE, RD ;
LIETMAN, PS ;
SMITH, CR .
JOURNAL OF INFECTIOUS DISEASES, 1987, 155 (01) :93-99